Data compiled by Redley Lamar · ChainSifter Intelligence
0Suppliers
6Customers
1Debt Items
20Related Chains
Source-Backed Evidence Depth
Anika Therapeutics, Inc. (ANIK) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
8Total relationships
1Distinct source URLs
5High confidence
0.785Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Anika Therapeutics, Inc. Suppliers
No suppliers on recordAnika Therapeutics, Inc. has not yet been matched to upstream suppliers in our database, or is still being processed.
Anika Therapeutics, Inc. Customers
Ticker
Name
Confidence
Evidence
JOHNSON-JOHNSON-MEDTECH
JOHNSON-JOHNSON-MEDTECH
92%
Revenue from the Company’s sole significant customer, Johnson & Johnson MedTech (‘J&J MedTech’), part of the Johnson & Johnson Medical Companies, as a percentage of the Company’s total revenue was 47…
l. The Company had no accrued warranties as of March 31, 2026, or December 31, 2025, and has no history of claims paid. 12 The Company is also involved from time-to-time in various legal proceedings …
Reciprocal relationship from JNJ graph: Reciprocal relationship from ANIK graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from ANIK graph: Reciprocal relationship from JNJ grap…
CAPITAL-RESOURCES
CAPITAL-RESOURCES
62%
$ 3,444 13 % Revenue for the three-month period ended March 31, 2026, was $29.6 million, an increase of $3.4 million, or 13%, compared to the same period in 2025. The increase in revenue was driven b…
INCENTIVE-PLANS-EQUITY-INCENTIVE-PLANS-THE-ANIKA
INCENTIVE-PLANS-EQUITY-INCENTIVE-PLANS-THE-ANIKA
62%
l. The Company had no accrued warranties as of March 31, 2026, or December 31, 2025, and has no history of claims paid. 12 The Company is also involved from time-to-time in various legal proceedings …
PLAN-THE-ANIKA-THERAPEUTICS-INC
PLAN-THE-ANIKA-THERAPEUTICS-INC
62%
l. The Company had no accrued warranties as of March 31, 2026, or December 31, 2025, and has no history of claims paid. 12 The Company is also involved from time-to-time in various legal proceedings …
Anika Therapeutics, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
ANIK-DEBT
Debt stack $26.6M
90%
Market cache reports total debt of $26.6M.
Anika Therapeutics, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Anika Therapeutics, Inc..
Anika Therapeutics, Inc. Ownership
Holder
Name
Confidence
Evidence
ANIK-OWNER-MORGAN-STANLEY
MORGAN STANLEY
90%
13F overlay lists MORGAN STANLEY as top holder; 129 tracked holders.
Anika Therapeutics, Inc. Extended Supply Chain Network
